Thorsten Kuhn
Overview
Explore the profile of Thorsten Kuhn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banys-Paluchowski M, Hartmann S, Basali T, Gasparri M, de Boniface J, Gentilini O, et al.
Breast Cancer Res Treat
. 2025 Feb;
PMID: 39976867
Background: Surgical staging procedures of the axilla in initially clinically node-positive (cN +) breast cancer patients receiving neoadjuvant chemotherapy (NACT) vary across countries. Different procedures such as axillary lymph node...
2.
Reimer T, Stachs A, Veselinovic K, Kuhn T, Heil J, Polata S, et al.
N Engl J Med
. 2024 Dec;
392(11):1051-1064.
PMID: 39665649
Background: Whether surgical axillary staging as part of breast-conserving therapy can be omitted without compromising survival has remained unclear. Methods: In this prospective, randomized, noninferiority trial, we investigated the omission...
3.
Lukac S, Leinert E, Kuhn T, Dayan D, Ebner F, Pfister K, et al.
Eur J Surg Oncol
. 2024 Nov;
51(1):108779.
PMID: 39489040
Background: The current standard for the preoperative marking of non-palpable breast lesions is wire guided localization (WGL) which is associated with logistical efforts and patient discomfort. Non-radioactive seeds (NRS) recently...
4.
Krawczyk N, Kuhn T, Ditsch N, Hartmann S, Gentilini O, Lebeau A, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410007
Background: Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory breast condition often mistaken for inflammatory breast cancer and, therefore, requires a biopsy for accurate diagnosis. Although not cancerous, IGM...
5.
Tvedskov T, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Frisell J, et al.
Lancet Reg Health Eur
. 2024 Oct;
47:101083.
PMID: 39386258
Background: Randomized trials have shown that axillary clearance (AC) can safely be omitted in patients with sentinel lymph node-positive breast cancer. At the same time, de-escalation of chemotherapy in postmenopausal...
6.
Skarping I, Bendahl P, Szulkin R, Alkner S, Andersson Y, Bergkvist L, et al.
JAMA Surg
. 2024 Sep;
159(12):1393-1403.
PMID: 39320882
Importance: In patients with clinically node-negative (cN0) breast cancer and 1 or 2 sentinel lymph node (SLN) macrometastases, omitting completion axillary lymph node dissection (CALND) is standard. High nodal burden...
7.
de Boniface J, Appelgren M, Szulkin R, Alkner S, Andersson Y, Bergkvist L, et al.
Lancet Oncol
. 2024 Aug;
25(9):1222-1230.
PMID: 39121881
Background: In luminal breast cancer, adjuvant CDK4/6 inhibitors (eg, abemaciclib) improve invasive disease-free survival. In patients with T1-2, grade 1-2 tumours, and one or two sentinel lymph node metastases, completion...
8.
Thill M, Janni W, Albert U, Banys-Paluchowski M, Bauerfeind I, Blohmer J, et al.
Breast Care (Basel)
. 2024 Jun;
19(3):183-191.
PMID: 38894953
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2024 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally...
9.
Park-Simon T, Muller V, Albert U, Banys Paluchowski M, Bauerfeind I, Blohmer J, et al.
Breast Care (Basel)
. 2024 Jun;
19(3):165-182.
PMID: 38894952
Introduction: Each year the interdisciplinary AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Breast Committee on Diagnosis and Treatment of Breast Cancer provides updated state-of-the-art recommendations for early and metastatic...
10.
Alkner S, Wieslander E, Lundstedt D, Berg M, Kristensen I, Andersson Y, et al.
Radiother Oncol
. 2024 Jun;
197:110372.
PMID: 38866204
Background And Purpose: Recommendations for regional radiotherapy (RT) of sentinel lymph node (SLN)-positive breast cancer are debated. We here report a RT quality assessment of the SENOMAC trial. Materials And...